Javier Santibáñez

868 total citations
63 papers, 498 citations indexed

About

Javier Santibáñez is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Javier Santibáñez has authored 63 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 21 papers in Infectious Diseases and 11 papers in Microbiology. Recurrent topics in Javier Santibáñez's work include Fungal Infections and Studies (22 papers), Antifungal resistance and susceptibility (18 papers) and Nail Diseases and Treatments (12 papers). Javier Santibáñez is often cited by papers focused on Fungal Infections and Studies (22 papers), Antifungal resistance and susceptibility (18 papers) and Nail Diseases and Treatments (12 papers). Javier Santibáñez collaborates with scholars based in Mexico, United Kingdom and United States. Javier Santibáñez's co-authors include Alexandro Bonifáz, Andrés Tirado‐Sánchez, Amado Saúl, Gloria M. González, Rosa María Ponce, Fernando Gómez-Bezares Pascual, Denisse Vázquez‐González, Alejandra Rosales, Miguel Ángel Sánchez-Alemán and Н Н Климко and has published in prestigious journals such as PLoS neglected tropical diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene and Medical Mycology.

In The Last Decade

Javier Santibáñez

55 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Santibáñez Mexico 13 284 223 129 120 103 63 498
Marcelo Rosandiski Lyra Brazil 16 331 1.2× 195 0.9× 31 0.2× 48 0.4× 55 0.5× 52 624
Alberto Thomaz Londero Brazil 11 378 1.3× 300 1.3× 40 0.3× 87 0.7× 54 0.5× 26 426
Roongnapa Pracharktam Thailand 11 418 1.5× 243 1.1× 53 0.4× 217 1.8× 25 0.2× 18 496
Richard C. Barton United Kingdom 6 268 0.9× 316 1.4× 7 0.1× 53 0.4× 108 1.0× 7 428
Mary Ann Robledo Colombia 12 379 1.3× 278 1.2× 7 0.1× 59 0.5× 74 0.7× 20 551
Kevin May Canada 10 358 1.3× 265 1.2× 14 0.1× 205 1.7× 7 0.1× 19 454
Andréia Ferreira Nery Brazil 10 173 0.6× 140 0.6× 11 0.1× 16 0.1× 69 0.7× 24 310
Gustavo Rivero United States 7 260 0.9× 279 1.3× 4 0.0× 63 0.5× 22 0.2× 35 399
Leire López-Soria Spain 11 190 0.7× 220 1.0× 7 0.1× 29 0.2× 63 0.6× 22 362
S. Mathoulin France 7 429 1.5× 351 1.6× 3 0.0× 14 0.1× 56 0.5× 11 473

Countries citing papers authored by Javier Santibáñez

Since Specialization
Citations

This map shows the geographic impact of Javier Santibáñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Santibáñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Santibáñez more than expected).

Fields of papers citing papers by Javier Santibáñez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Santibáñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Santibáñez. The network helps show where Javier Santibáñez may publish in the future.

Co-authorship network of co-authors of Javier Santibáñez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Santibáñez. A scholar is included among the top collaborators of Javier Santibáñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Santibáñez. Javier Santibáñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonifáz, Alexandro, et al.. (2024). Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant to conventional treatments. Expert Review of Anti-infective Therapy. 23(1). 79–89. 1 indexed citations
2.
Chavez, Cleofe J., et al.. (2024). Clinical and Biochemical Characteristics of Hemophagocytic Lymphohistiocytosis in People Living With HIV and Disseminated Histoplasmosis at a Tertiary Hospital in Mexico. Open Forum Infectious Diseases. 11(7). ofae385–ofae385. 1 indexed citations
3.
Santibáñez, Javier, et al.. (2023). Review Article White Piedra: Review of 131 cases. Mycoses. 67(1). e13668–e13668. 3 indexed citations
4.
Bonifáz, Alexandro, et al.. (2020). Actinomycetoma by Actinomadura madurae . Clinical and therapeutic characteristics of 18 cases with two treatment modalities. Journal of Dermatological Treatment. 33(2). 954–958. 9 indexed citations
5.
Santibáñez, Javier, et al.. (2018). Actinomycetoma due to Actinomadura madurae: A therapeutic challenge. Case report. Our Dermatology Online. 9(4). 399–403. 1 indexed citations
6.
Santibáñez, Javier, et al.. (2017). Alerta epidemiológica: infección por Candida auris. 61(6). 533–536. 1 indexed citations
7.
Santibáñez, Javier, et al.. (2014). Cost of funds on the basis of Modigliani and Miller and CAPM propositions: a revision. 6–19. 1 indexed citations
8.
Santibáñez, Javier, et al.. (2013). Onicomicosis de mano causada por tres especies de Candida. 11(1). 23–25. 1 indexed citations
9.
Pascual, Fernando Gómez-Bezares & Javier Santibáñez. (2011). Perspectiva histórica de la financiación empresarial. 115–143. 2 indexed citations
10.
Santibáñez, Javier, et al.. (2009). Evaluación de sensibilidad y especificidad del agar Harina de maíz + tween 80, CHROMagar Candida y MicroScan para la identificación de especies aisladas de Candida. 21(4). 79–84. 1 indexed citations
11.
Pascual, Fernando Gómez-Bezares, et al.. (2007). Índices de performance, gestión activa y eficiencia. Un análisis empírico. Revista Europea de Dirección y Economía de la Empresa. 16(2). 21–40.
12.
Valencia, Adriana, et al.. (2007). Tiña de la cabeza. Reporte de 122 casos. 5(1). 9–14. 3 indexed citations
13.
Pascual, Fernando Gómez-Bezares, Jesús García de Madariaga, & Javier Santibáñez. (2004). Performance ajustada al riesgo. 12(93). 6–17. 1 indexed citations
14.
Pascual, Fernando Gómez-Bezares, Jesús García de Madariaga, & Javier Santibáñez. (2003). Medidas de performance: algunos índices clásicos y relación de la TRIP con la teoría de cartera. 30(113). 5–19. 2 indexed citations
15.
Pascual, Fernando Gómez-Bezares, Jesús García de Madariaga, & Javier Santibáñez. (2000). Algunas relaciones interesantes entre inversión y financiación. Dialnet (Universidad de la Rioja). 307–327. 1 indexed citations
16.
Pascual, Fernando Gómez-Bezares, Jesús García de Madariaga, & Javier Santibáñez. (1999). Riesgo y rentabilidad en mercados de tamaño intermedio (el caso español). 52–74. 1 indexed citations
17.
Pascual, Fernando Gómez-Bezares & Javier Santibáñez. (1997). Cálculo y gestión del valor de la empresa. Boletín de Estudios Económicos. 52(162). 197–220. 1 indexed citations
18.
Pascual, Fernando Gómez-Bezares & Javier Santibáñez. (1996). Modelos de valoración y eficiencia: ¿bate el CAPM al mercado?. 72–96. 2 indexed citations
19.
Pascual, Fernando Gómez-Bezares, Jesús García de Madariaga, & Javier Santibáñez. (1995). VAN vs TRI: algunos ejemplos prácticos. Dialnet (Universidad de la Rioja). 151–172. 1 indexed citations
20.
Santibáñez, Javier. (1995). El tratamiento del riesgo en la decisión de inversión: VAP y distribuciones no conocidas. Boletín de Estudios Económicos. 50(154). 119–140. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026